Article Versions Notes

Plaunt AJ, Islam S, Macaluso T, Gauani H, Baker T, Chun D, Viramontes V, Chang C, Corboz MR, Chapman RW, et al. Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 2021; 22(2):548. https://doi.org/10.3390/ijms22020548

Plaunt, Adam J., Sadikul Islam, Tony Macaluso, Helena Gauani, Thomas Baker, Donald Chun, Veronica Viramontes, Christina Chang, Michel R. Corboz, Richard W. Chapman, and et al. 2021. "Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension" International Journal of Molecular Sciences 22, no. 2: 548. https://doi.org/10.3390/ijms22020548

Plaunt, A. J., Islam, S., Macaluso, T., Gauani, H., Baker, T., Chun, D., Viramontes, V., Chang, C., Corboz, M. R., Chapman, R. W., Li, Z., Cipolla, D. C., Perkins, W. R., & Malinin, V. S. (2021). Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension. International Journal of Molecular Sciences, 22(2), 548. https://doi.org/10.3390/ijms22020548